Emerging evidence suggests that muscle quality plays a crucial role in determining the prognosis of patients with chronic heart failure (HF). However, few studies have explored the prognostic value of muscle quality using both structural and functional indicators. This study aimed to investigate whether a comprehensive assessment of muscle quality-evaluating both intramuscular fat (IMF) content and muscle-related neurotrophic factors-could enhance risk stratification in HF with reduced ejection fraction (HFrEF).
View Article and Find Full Text PDFEsaxerenone, a non-steroidal mineralocorticoid receptor (MR) blocker, exhibits high selectivity for MR. While clinically used as an anti-hypertensive drug, its impact on cardiac remodeling remains poorly understood. This study investigated the effect of esaxerenone on pressure overload-induced cardiac hypertrophy in mice.
View Article and Find Full Text PDFFront Cardiovasc Med
November 2023
J Vasc Interv Radiol
February 2022